Exemestane
Exemestane is a prescription medication available as 25 mg oral tablets, manufactured by Breckenridge Pharmaceutical, Inc. It belongs to the aromatase inhibitor class and is used to treat hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen production. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Exemestane is a prescription medication available as 25 mg oral tablets, manufactured by Breckenridge Pharmaceutical, Inc. It belongs to the aromatase inhibitor class and is used to treat hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen production. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Exemestane",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Exemestane — ANDA 211031 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211031"
}
]
|
| identifier | ANDA211031 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Exemestane |
